PubTransformer

A site to transform Pubmed publications into these bibliographic reference formats: ADS, BibTeX, EndNote, ISI used by the Web of Knowledge, RIS, MEDLINE, Microsoft's Word 2007 XML.




PMID- 28445661
OWN - NLM
STAT- MEDLINE
DA  - 20170426
DCOM- 20170428
LR  - 20170503
IS  - 1533-4406 (Electronic)
IS  - 0028-4793 (Linking)
VI  - 376
IP  - 17
DP  - 2017 Apr 27
TI  - Ocrelizumab in Primary Progressive and Relapsing Multiple Sclerosis.
PG  - 1694
LID - 10.1056/NEJMc1702076 [doi]
FAU - Hauser, Stephen L
AU  - Hauser SL
AD  - University of California, San Francisco, San Francisco, CA.
      [email protected]
FAU - Belachew, Shibeshih
AU  - Belachew Sh
AD  - F. Hoffmann-La Roche, Basel, Switzerland
FAU - Kappos, Ludwig
AU  - Kappos L
AD  - University Hospital Basel, Basel, Switzerland
LA  - eng
PT  - Letter
PT  - Comment
PL  - United States
TA  - N Engl J Med
JT  - The New England journal of medicine
JID - 0255562
SB  - AIM
SB  - IM
CON - N Engl J Med. ;376(17 ):1692-3. PMID: 28447770
CON - N Engl J Med. 2017 Apr 27;376(17 ):1693. PMID: 28445662
CON - N Engl J Med. ;376(17 ):1693-4. PMID: 28447771
MH  - Humans
MH  - *Multiple Sclerosis
MH  - *Multiple Sclerosis, Relapsing-Remitting
MH  - Recurrence
EDAT- 2017/04/27 06:00
MHDA- 2017/04/30 06:00
CRDT- 2017/04/27 06:00
AID - 10.1056/NEJMc1702076 [doi]
PST - ppublish
SO  - N Engl J Med. 2017 Apr 27;376(17):1694. doi: 10.1056/NEJMc1702076.

<?xml version="1.0" encoding="UTF-8"?>
<b:Sources SelectedStyle="" xmlns:b="http://schemas.openxmlformats.org/officeDocument/2006/bibliography"  xmlns="http://schemas.openxmlformats.org/officeDocument/2006/bibliography" >
</b:Sources>